Drug Shortage Report for OLESTYR
Report ID | 204499 |
Drug Identification Number | 00890960 |
Brand name | OLESTYR |
Common or Proper name | OLESTYR |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | CHOLESTYRAMINE RESIN |
Strength(s) | 4G |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 30x4g |
ATC code | C10AC |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-09-15 |
Estimated end date | 2026-11-01 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | Yes |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2024-10-30 | French | Compare |
v10 | 2024-10-30 | English | Compare |
v9 | 2024-07-22 | French | Compare |
v8 | 2024-07-22 | English | Compare |
v7 | 2024-01-30 | English | Compare |
v6 | 2023-12-27 | English | Compare |
v5 | 2023-12-22 | French | Compare |
v4 | 2023-12-22 | English | Compare |
v3 | 2023-09-16 | English | Compare |
v2 | 2023-09-15 | French | Compare |
v1 | 2023-09-15 | English | Compare |
Showing 1 to 11 of 11